Cargando…
Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence
Acthar(®) Gel (repository corticotropin injection [RCI]) is a naturally sourced complex mixture of adrenocorticotropic hormone analogs and other pituitary peptides used to treat patients with serious and rare inflammatory and autoimmune conditions. This narrative review summarizes the key clinical a...
Autores principales: | Wan, George J, Niewoehner, John, Hayes, Kyle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312382/ https://www.ncbi.nlm.nih.gov/pubmed/37397803 http://dx.doi.org/10.2147/CEOR.S410082 |
Ejemplares similares
-
Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis
por: Hayes, Kyle, et al.
Publicado: (2023) -
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis
por: Bindra, Jas, et al.
Publicado: (2023) -
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus
por: Bindra, Jas, et al.
Publicado: (2022) -
A Narrative Review of Acthar Gel for the Treatment of Myositis
por: Chandra, Tanya, et al.
Publicado: (2023) -
Acthar Gel Inhibits the Activation of CD4(+) and CD8(+) T Cells
por: Wright, Dale, et al.
Publicado: (2023)